We want to be your partner and drive pioneering therapies to the market. We invest in enabling technologies and build expertise to support the development and commercialization of your new innovative therapy. Our scientists and engineers bring decade-long development experience across a broad spectrum of cell types and technologies. This builds the backbone of an extensive service offering, providing you with tailored process and analytical development, manufacturing and regulatory services. www.pharma.lonza.com/cell-and-gene-therapy
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times.We offer a full range of consulting, development and commercialisation services from a global network of offices in 38 countries. Read more here.
LeukoDx has developed a revolutionary cartridge-based multi-wavelength fluorescent event detection and analysis platform for rapid and efficient measurement and characterization of fluorescently labeled cells and beads to enable multiplexed immunoassays. LeukoDx’s Accellix platform is a no prep, push-button cell enumeration and characterization platform that can provide multiple fluorescent marker information in a single cartridge with close to real time access, 24/7 when and where critical decisions must be made. LeukoDx has offices in San Jose, CA and Jerusalem, Israel. www.LeukoDx.com
MaxCyte’s flow electroporation is driving the next generation of cell-based medicines. Used in the discovery, development, and manufacture of cell-based therapeutics, the MaxCyte GT® Flow Transfection System, MaxCyte STX® Scalable Transfection System, and MaxCyte VLX® Large Scale Transfection System enable the development of transfected cells for a range of applications.
Nuvera partners with specialty pharma/biotech companies to design and implement holistic Treatment Support Programs that enhance the overall treatment experience. We’ve worked with a multitude of top 20 specialty companies across therapeutic areas, including CAR-T. In today’s market, a great product is not enough. The overall Brand treatment experience is what determines how widely a product is used. We leverage the depth of our experience, innovative thinking, and patient centricity to create exceptional brand experiences.
Promab Biotechnologies provides a completely comprehensive CAR-T pre-clinical package, allowing for accelerated proof-of-concept, and IP positioning, beginning with the generation of a mouse, rabbit, or human (library) monoclonal antibody, or with the synthesis and cloning of existing antibody sequence into a CAR expression construct. Promab is positioned to explore collaboration with partners in order to rapidly expand clinical targets. Read more here.
Quick is the trusted leader in personalized medicine transportation, delivering chain of custody and certified quality control processes for your gene and cell therapies–from APH to infusion, clinical to commercial supply chain planning. Our customized global logistics solutions help ensure product integrity and patient safety for your cutting-edge treatments. Read more here.
Thermo as the world leader in serving science, Thermo Fisher Scientific is uniquely positioned to provide the quality materials, services and support needed to accelerate the pace of advanced therapy development. We understand the complexity of this rapidly evolving industry and partner with our customers as they transition from discovery to clinical research and commercial manufacturing. Read more here.
Vineti combines industry-leading software expertise with deep first-hand, knowledge of commercializing personalized cell therapies to digitize the supply chain, manufacturing and compliance systems for the delivery of transformational medicines. Vineti’s user-centric design creates a platform that is easier for physicians, nurses, and manufacturing operations to use, resulting in a superior user experience and reduced risk. The Vineti platform provides actionable insights to continually optimize the process, accelerating time to revenue and decreasing costs.
Blood Centers of America (BCA) is a national network of over 50 independent blood centers with just over 600 fixed collection and testing sites positioned throughout the country. BCA and its members provide a variety of human blood products, cells and tissues to the therapeutic, diagnostic and cell therapy industries. Whether you are sourcing research or clinical grade materials; blood or tissue derived products, or custom collections and/or collection services, BCA has a solution for you. Read more here.